Back
Despegar.com Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
39
DESP
Despegar.com
Last Price:
13.16
Seasonality Move:
-15.48%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
156.66
Seasonality Move:
18.65%
Sell
39
Despegar.com (DESP)
is a Sell
Is Despegar.com a Buy, Sell or Hold?
- The current Despegar.com [DESP] share price is $13.16. The Score for DESP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- DESP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $157.96. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DESP Stock Price Chart
What is Despegar.com's stock price today?
-
The Despegar.com share price today is $13.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DESP is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $157.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
DESP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 44.85 | Sell |
| Chaikin Money Flow: | 552294 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.41 - 15.05) | Sell |
| Bollinger Bands (100): | (9.67 - 13.97) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.07 | Buy |
| Relative Strength Index (14 RSI): | 68.93 | Buy |
| Chaikin Money Flow: | 909555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.85 - 144.93) | Buy |
| Bollinger Bands (100): | (118.68 - 136.96) | Buy |
DESP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.2 | Sell |
| 20-day SMA: | 14.05 | Sell |
| 50-day SMA: | 13.43 | Sell |
| 200-day SMA: | 9.92 | Buy |
| 8-day EMA: | 13.24 | Sell |
| 20-day EMA: | 13.65 | Sell |
| 50-day EMA: | 13.29 | Sell |
| 200-day EMA: | 10.69 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 144.42 | Buy |
| 20-day SMA: | 131.3 | Buy |
| 50-day SMA: | 128.76 | Buy |
| 200-day SMA: | 115.64 | Buy |
| 8-day EMA: | 148.13 | Buy |
| 20-day EMA: | 137 | Buy |
| 50-day EMA: | 130.51 | Buy |
| 200-day EMA: | 121.04 | Buy |
Despegar.com Earnings Growth & DESP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.37 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Despegar.com Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||